These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Diffuse gliomas to date and beyond 2016 WHO Classification of Tumours of the Central Nervous System. Onizuka H; Masui K; Komori T Int J Clin Oncol; 2020 Jun; 25(6):997-1003. PubMed ID: 32468200 [TBL] [Abstract][Full Text] [Related]
6. An Update on Pediatric Gliomas. Ahrendsen J; Alexandrescu S Surg Pathol Clin; 2020 Jun; 13(2):217-233. PubMed ID: 32389263 [TBL] [Abstract][Full Text] [Related]
7. Understanding the Revised Fourth Edition of the World Health Organization Classification of Tumours of the Central Nervous System (2016) for Clinical Decision-making: A Guide for Oncologists Managing Patients with Glioma. Back M; Rodriguez M; Jayamanne D; Khasraw M; Lee A; Wheeler H Clin Oncol (R Coll Radiol); 2018 Sep; 30(9):556-562. PubMed ID: 29980381 [TBL] [Abstract][Full Text] [Related]
8. Low-grade central nervous system tumors. Lopes MB; Laws ER Neurosurg Focus; 2002 Feb; 12(2):E1. PubMed ID: 16212318 [TBL] [Abstract][Full Text] [Related]
9. Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study. Marko NF; Prayson RA; Barnett GH; Weil RJ Genomics; 2010 Jan; 95(1):16-24. PubMed ID: 19835948 [TBL] [Abstract][Full Text] [Related]
10. Genetic markers in adult high-grade gliomas. Pekmezci M; Perry A Semin Radiat Oncol; 2014 Oct; 24(4):235-9. PubMed ID: 25219807 [TBL] [Abstract][Full Text] [Related]
11. [CLINICAL GUIDELINES FOR DIAGNOSING, TREATING AND MONITORING OF ADULT PATIENTS WITH GLIOMAS OF CENTRAL NERVOUS SYSTEM]. Krpan AM; Juretić A; Boban M; Omrcen T; Paladino J; Hajnsek S; Zarković K; Rados M; Pavlovic-Ruzić I; Rakusić Z; Radić J; Erić S; Misir M; Forenpoher G; Dolić K Lijec Vjesn; 2015; 137(11-12):343-7. PubMed ID: 26975062 [TBL] [Abstract][Full Text] [Related]
12. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging. Liao W; Liu Y; Wang X; Jiang X; Tang B; Fang J; Chen C; Hu Z Acta Radiol; 2009 Mar; 50(2):217-25. PubMed ID: 19096950 [TBL] [Abstract][Full Text] [Related]
13. Gliofibroma: a report of three cases and review of literature. Goyal S; Puri T; Gunabushanam G; Sharma MC; Sarkar C; Julka PK; Rath GK Acta Oncol; 2007; 46(8):1202-4. PubMed ID: 17851847 [No Abstract] [Full Text] [Related]
14. Optimal diagnosis by using two-marker studies. Smith GT; Isidoro F; Thie JA; Hubner KF Radiology; 2003 Jul; 228(1):292-3; author reply 293. PubMed ID: 12832591 [No Abstract] [Full Text] [Related]
16. Glioma: a continuing challenge and a mystery? Muzumdar D Indian J Cancer; 2009; 46(2):79-81. PubMed ID: 19346640 [No Abstract] [Full Text] [Related]
17. Central nervous system tumors. Jacques G; Cormac O Handb Clin Neurol; 2013; 112():931-58. PubMed ID: 23622303 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic molecular markers in common adult gliomas. Rivera AL; Pelloski CE Expert Rev Mol Diagn; 2010 Jul; 10(5):637-49. PubMed ID: 20629512 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution. Combs SE; Thilmann C; Edler L; Debus J; Schulz-Ertner D J Clin Oncol; 2005 Dec; 23(34):8863-9. PubMed ID: 16314646 [TBL] [Abstract][Full Text] [Related]
20. Differentiating primary central nervous system (CNS) lymphoma from "butterfly glioma": A case report. Bragin A; Safouris A; Bourgonjon B; Michotte A; Triantafyllou N; Tsivgoulis G J Neurol Sci; 2015 Jul; 354(1-2):114-5. PubMed ID: 25982183 [No Abstract] [Full Text] [Related] [Next] [New Search]